Phase I Study of Docetaxel and Temsirolimus in Resistant Solid Malignancies

NCT00703625 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Resistant Solid Malignancies

Interventions

DRUG: Temsirolimus
DRUG: Docetaxel

Sponsor

Washington University School of Medicine